NASDAQ:SBFMW Sunshine Biopharma (SBFMW) Stock Price, News & Analysis $0.02 0.00 (0.00%) As of 09:37 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock About Sunshine Biopharma Stock (NASDAQ:SBFMW) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Sunshine Biopharma alerts:Sign Up Key Stats Today's Range$0.03▼$0.0350-Day Range$0.03▼$0.1652-Week Range$0.03▼$0.65Volume25,185 shsAverage Volume11,329 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Sunshine Biopharma is a development-stage biopharmaceutical company focused on the discovery and development of novel small-molecule therapeutics for oncology and antiviral applications. The company’s research activities encompass the design, synthesis and preclinical evaluation of compounds that inhibit key pathways involved in cell proliferation and viral replication. Among its lead programs, Sunshine Biopharma is advancing Adva-27a, a topoisomerase II inhibitor licensed from the National Research Council of Canada, which is undergoing preclinical studies for potential use in breast and ovarian cancers. In parallel, the company is exploring polyamine modulators and other proprietary molecules aimed at disrupting cancer cell metabolism and addressing unmet medical needs in viral diseases. Sunshine Biopharma holds exclusive global rights to a portfolio of patents and patent applications covering its drug candidates. The company collaborates with contract research organizations and academic institutions to support preclinical toxicology, pharmacology and formulation development, laying the groundwork for future regulatory filings. Headquartered in Mont-Saint-Hilaire, Quebec, Sunshine Biopharma is positioned to serve North American markets and aims to expand its reach globally upon regulatory approvals. Its management team brings experience in medicinal chemistry, pharmaceutical development and regulatory affairs to guide the company through its pre-commercial stages.AI Generated. May Contain Errors. Read More Receive SBFMW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sunshine Biopharma and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SBFMW Stock News HeadlinesSunshine Biopharma Inc.: Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment TechnologyMay 29, 2026 | finanznachrichten.deSBFMW Sunshine Biopharma, Inc. WT EXP 021527May 19, 2026 | seekingalpha.comFree: The Crypto Summit That Could Change Your Life27 of the top crypto experts in the world… multi-millionaires, fund managers, coin creators, underground traders… are coming together at the Crypto Community Summit to share exactly what they're doing in this market. Not what they think in theory. What they're actually doing with their own money. The Clarity Act is weeks from potentially becoming law. Warsh is cutting rates. Corporate giants are loading up on crypto. Prices may be down now… But this summer could be historic.June 10 at 1:00 AM | Crypto 101 Media (Ad)Sunshine Biopharma Inc.: Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior YearApril 6, 2026 | finanznachrichten.deSunshine Biopharma (SBFM) price target decreased by 14.29% to 6.12December 7, 2025 | msn.comSunshine Biopharma Boosts Retail Trader Appeal After Canadian Launch Of Generic Cancer DrugApril 22, 2025 | msn.comSunshine Biopharma reports FY24 revenue $34.9M vs $24.1M last yearApril 3, 2025 | markets.businessinsider.comSunshine Biopharma announces results from studies on K1.1-mRNA-LNP productApril 3, 2025 | markets.businessinsider.comSee More Headlines SBFMW Stock Analysis - Frequently Asked Questions How have SBFMW shares performed this year? Sunshine Biopharma's stock was trading at $0.1650 on January 1st, 2026. Since then, SBFMW shares have decreased by 84.5% and is now trading at $0.0255. How do I buy shares of Sunshine Biopharma? Shares of SBFMW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today6/10/2026Next Earnings (Estimated)8/05/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (5d) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 As of 5 days ago, SBFMW's financial health entered the Red zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:SBFMW CIK1402328 Webwww.sunshinebiopharma.com Phone514-426-6161FaxN/AEmployees3Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$35.49 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (NASDAQ:SBFMW) was last updated on 6/10/2026 by MarketBeat.com Staff. From Our PartnersHe Called NVIDIA at $1.10 – Now He Says, “SELL”The analyst who called NVIDIA at $1.10 now says sell. According to Alexander Green, Chief Investment Strategis...The Oxford Club | SponsoredFree: The Crypto Summit That Could Change Your Life27 of the top crypto experts in the world… multi-millionaires, fund managers, coin creators, underground trade...Crypto 101 Media | SponsoredYour name isn't on our protected list yetI checked our download records for "The Big Beautiful Bubble Report" and didn't see your name. That concern...American Alternative | SponsoredI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,0...Brownstone Research | SponsoredThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...Banyan Hill Publishing | SponsoredStranded On The Flood Plains of HistoryThe petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed...Porter & Company | SponsoredOne hidden supplier shipped 5 billion parts to SpaceXMost investors are focused on the historic $1.75 trillion SpaceX IPO expected around June 30. But there's a le...Weiss Ratings | SponsoredTesla. SolarCity. Twitter. This $4 stock is next.Elon Musk has a clear pattern: when a supplier becomes mission-critical, he acquires it. He bought SolarCity f...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sunshine Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sunshine Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SBFMW Stock Alerts